Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Magazine

Table: Betting on Biotech


Bill Gates has dabbled in biomedicine for more than a decade. His stakes in biotech companies now top $300 million. Meanwhile his foundation has spent $3.1 billion on global health matters -- about 52% of its total grants. Here's how the investments line up:

Personal Biotech Holdings

CORIXA drugs for cancer and infectious diseases

GENECRAFT drugs for cancer and inflammation

ICOS erectile dysfunction drug

PAIN THERAPEUTICS painkillers

SEATTLE GENETICS cancer therapies

The Bill & Melinda Gates Foundation

$750 MILLION for childhood immunizations in developing countries

$100 MILLION research grant to the International AIDS Vaccine Initiative

$70 MILLION to fight epidemic meningitis in sub-Saharan Africa

$28 MILLION to fight schistosomiasis, a parasitic disease


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus